Interventional Cardiology and Peripheral Vascular Devices Market Size, Share and Trends 2026 to 2035
Interventional Cardiology and Peripheral Vascular Devices Market (By Product Type: Angioplasty Stents, Angioplasty Balloons, Plaque Modification Devices, Hemodynamic Flow Alteration, Structural Heart Devices, Accessories; By Application: Coronary Artery Disease (CAD), Peripheral Arterial Disease (PAD), Aneurysms & Venous Diseases; By End User: Hospitals, Ambulatory Surgical Centres (ASCs)) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035
Get a Sample
Table Of Content
What is the Interventional Cardiology and Peripheral Vascular Devices Market Size in 2026?
The global interventional cardiology and peripheral vascular device market size was calculated at USD 27.96 billion in 2025 and is predicted to increase from USD 30.36 billion in 2026 to approximately USD 63.80 billion by 2035, expanding at a CAGR of 8.60% from 2026 to 2035.The interventional cardiology and peripheral vascular device market is growing because of the growing prevalence of cardiovascular disease and the increasing ageing population.
Key Takeaways
- North America dominated the interventional cardiology peripheral vascular device market with largest share of 29% in 2025.
- Asia Pacific is expected to be the fastest-growing region between 2026 and 2035.
- By product type, the angioplasty stents segment held a dominant position in the market in 2025.
- By product type, the catheters segment is expected to grow at the fastest CAGR during the forecast period.
- By application, the coronary artery disease (CAD) segment led the global interventional cardiology and peripheral vascular device market in 2025.
- By application, the peripheral arterial disease (PAD) segment is expected to witness the fastest growth in the market with a CAGR over the forecast period.
- By end-user, the hospitals segment registered its dominance over the global market with 87% share in 2025.
- By end-user, the ambulatory surgical centres (ASCs) segment is expected to expand rapidly in the market with a CAGR in the coming years.
Market Overview
The interventional cardiology and peripheral vascular device market covers medical devices used to treat narrowed or blocked blood vessels through minimally invasive procedures. These include drug-coated balloons, coronary stents, catheters, and atherectomy systems. The need for these devices continues to grow as coronary artery disease and peripheral artery disease remain widespread, particularly among ageing populations and patients with diabetes and hypertension. Ongoing advancement in device design, safety, and procedural efficiency is helping physicians to deliver better treatment and faster recovery.
What is the Role of AI in the Market?
Artificial intelligence is transforming the interventional cardiology and peripheral vascular device market by making procedures more precise and predictable. AI helps to study patient data, imaging scans, which help in selecting the right stent, balloons, or device for each patient. It also assists in identifying patterns to detect early signs of complications, device malfunction, or disease progression. Machine learning helps to optimize the design and performance of the device to improve safety and streamline clinical workflow. Overall, the AI is supporting faster analysis and data-driven decision making, which contributes to safer procedures, better outcome and a more personalized approach to interventional cardiology and peripheral vascular treatment.
Interventional Cardiology and Peripheral Vascular Devices Market Trends
- Rising prevalence of cardiovascular disease, such as coronary artery disease and peripheral artery disease. Sedentary lifestyle, ageing population, obesity, diabetes, and hypertension are pushing demand for angioplasty, stenting, and other catheter-based vascular interventions across both developed and developing countries.
- Rapid advancement in interventional cardiology and peripheral vascular devices for better treatment outcomes. Drug-eluting stents, drug-coated balloons, and atherectomy systems are enhancing the procedural success rate. These advances improve patient safety by enabling real-time imaging and targeted drug delivery.
- Healthcare systems are focusing on outcome-driven care and cost control. Improved healthcare systems, ongoing research and development activities, and the introduction of bio-absorbable stents are contributing to the interventional cardiology and peripheral vascular device market's growth.
- Physicians and patients prefer minimally invasive treatment over surgeries, as they involve smaller incisions, less surgical pain, scarring, shorter hospital stays, quicker recovery, lower complication rates, and reduced overall treatment costs, which are driving demand for the adoption of interventional cardiology peripheral vascular devices.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 27.96 Billion |
| Market Size in 2026 | USD 30.36 Billion |
| Market Size by 2035 | USD 63.80 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 8.60% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product Type, Application, End User , and region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segmental Insights
Product Type Insights
Why Did the Angioplasty Stents Segment Hold the Largest Share of the Market?
The angioplasty stents segment registered its dominance over the global market in 2025. These devices are implanted after balloon dilation to keep the artery open and support steady blood flow. Drug-eluting stents are widely preferred because they release medication that lowers the chances of the artery narrowing again. Due to ongoing advancements for better design, thinner structure, and improved coating material, stents are safer to use and more reliable.
The catheters segment is expected to gain the highest CAGR in the interventional cardiology and peripheral vascular device market during the forecast period. They provide access to blood vessels and deliver stents, balloons, and other devices to the exact treatment site. These segments have steady demand due to rising procedure volumes and growing complexity of cases. Manufacturers are focusing on improved flexibility and control for use. Rising numbers of coronary and peripheral interventions across hospitals and speciality centres continue to support stable demand.
Application Insights
What Made the Coronary Artery Disease (CAD) Segment Lead the Market?
The coronary artery disease (CAD) segment dominated the global market in 2025. Patients with heart attacks or severe chest pain often require urgent angioplasty and stent placement. Drug-eluting stents, balloons, guidewires, and imaging-supported catheters are routinely used to restore blood flow safely. Cardiovascular disease is one of the leading health concerns globally, demands coronary interventions, and contributes to the growth of the segment.
The peripheral arterial disease (PAD) segment is expected to grow at the fastest CAGR in the interventional cardiology and peripheral vascular device market over the forecast period. Patients with diabetes or a long-term smoking history develop narrowed arteries in the legs or other peripheral vessels. For treatment, patients prefer minimally invasive treatment using drug-coated balloons, peripheral stents, and atherectomy devices. Early treatment helps to prevent serious complications like reduced mobility and limb loss.
End-user Insights
Why Did the Hospitals Segment Dominate the Device Market?
The hospitals segment accounted for the largest revenue share in the market in 2025 because it is a primary centre of contact for patients. Most complex vascular procedures, angioplasty and stenting, are performed in hospitals equipped with advanced imaging systems and emergency support. Critical cases, such as heart attacks and severe arterial blockages, are managed in hospital settings. Improved infrastructure, skilled specialists, and the ability to manage emergencies make the hospital a dominant segment in the market.
The ambulatory surgical centres (ASCs) segment is expected to witness the fastest growth in the interventional cardiology and peripheral vascular device market with a CAGR over the forecast period. These facilities focus on planned, minimally invasive procedures. Patients often prefer ASCs due to shorter waiting times and a more personalised experience. Although emergency cases are still managed and treated in hospitals, routine and lower-risk procedures are increasingly performed in ambulatory centres. Ambulatory surgical centres are cost-effective and provide better personal care as compared to large hospitals.
Regional Insights
North America Interventional Cardiology and Peripheral Vascular Devices Market Size and Growth 2026 to 2035
The North America Interventional Cardiology and Peripheral Vascular Devices market size is estimated at USD 8.11 billion in 2025 and is projected to reach approximately USD 18.82 billion by 2035, with a 8.78% CAGR from 2026 to 2035.
What Factors Made the North America Region the Dominant Region in the Market?
North America dominated the global interventional cardiology and peripheral vascular device market in 2025 due to the high prevalence of cardiovascular disease and strong healthcare infrastructure, specialised cardiac centres, and trained interventional cardiologists. Early adoption of new stents and catheter technology supports steady demand. The growing burden of lifestyle-related conditions such as diabetes, obesity, and hypertension keeps cases volume high. The region has high healthcare spending and supportive government policies, which support market expansion.
U.S. Interventional Cardiology and Peripheral Vascular Devices Market Size and Growth 2026 to 2035
The U.S. Interventional Cardiology and Peripheral Vascular Devices market size is calculated at USD 6.08 billion in 2025 and is expected to reach nearly USD 14.21 billion in 2035, accelerating at a strong CAGR of 8.86% between 2026 and 2035.
U.S. Market Trends
The U.S market is witnessing strong growth driven by high healthcare spending and widespread availability of advanced interventional devices and treatments. The presence of major manufacturers and continuous clinical research supports advancement in the treatment and devices. Cardiovascular disease is one of the leading health concerns in the region, and hospitals and surgical centres continue to rely on interventional devices. These factors collectively make the U.S. a major contributor to interventional cardiology and the peripheral vascular device market.
Why Is the Asia Pacific Growing with the Highest CAGR in the Market?
Asia Pacific is expected to grow at the fastest CAGR in the interventional cardiology and peripheral vascular device market during the forecast period. The growth is driven by the rising prevalence of cardiovascular disease and diabetes, the growing urban population, and changing diets, which contribute to more cardiovascular complications. This results in rising demand for angioplasty and other minimally invasive procedures in the region. Public and private hospitals are improving healthcare infrastructure to allow early diagnosis and treatment to prevent complications.
China Market Trends
China is one of the most important markets in the region due to its large patient population and rising incidence of cardiovascular disease. Government programs are making advanced healthcare facilities to support easy access to minimally invasive procedures. Hospitals are expanding their interventional departments and improving physician training to provide advanced treatment to patients. Growing awareness of early diagnosis and timely treatment is encouraging more patients to seek consultation. Domestic device manufacturers are also entering the market along with global companies, which increases competition within the market.
India Market Trends
India's market is growing steadily due to rising healthcare awareness, expanding hospital infrastructure, and increasing access to advanced medical treatments and devices. An increasing number of patients prefer minimally invasive procedures to shorten recovery time. Health insurance is expanding, and government healthcare programs and private hospital investments are contributing to wider access. Increased health insurance coverage and public awareness campaigns are encouraging early diagnosis and timely treatment, positioning India as one of the most promising emerging markets in the interventional cardiology and peripheral vascular device market.
Interventional Cardiology and Peripheral Vascular Devices Market Value Chain Analysis
- R&D
Research and development focus on developing safe and more durable stents, balloons, catheters, and imaging-supported devices to enhance device safety, performance, durability, and patient comfort.
Key Players: Boston Scientific Corporation, Abbott Laboratories, BD (Becton, Dickinson and Company), Edwards Lifesciences Corporation, Boston Scientific Corporation.
- Clinical Trials and Regulatory Approvals
Clinical trials evaluate the safety, reliability, and therapeutic effectiveness of the devices, while regulatory approvals ensure compliance with strict medical standards, to build trust among physicians, patients, and healthcare providers worldwide.
Key Players: Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Abbott Laboratories, Edwards Lifesciences Corporation.
- Packaging and Sterilization
Packaging and sterilization in interventional cardiology and peripheral vascular device markets ensure contamination-free delivery and compliance with medical safety protocols during transportation, storage, and hospital handling.
Key Players: STERIS Applied Sterilization Technologies (AST), Oliver Healthcare Packaging, Advant Medical, DuPont Spectrum, PAXXUS
- Distribution to Hospitals, Pharmacies
Distribution to hospitals, speciality clinics, and surgical centres involves timely delivery, inventory management, proper storage, and careful handling of devices, ensuring easy availability.
Key Players: Abbott Laboratories, BD (Becton, Dickinson and Company), Boston Scientific Corporation, Terumo Corporation, Cook Medical Inc.
- Patient Support and Services
Patient support services focus on device training, follow-up care, and technical assistance, helping patients adapt to medical devices, improve treatment adherence, and maintain long-term health outcomes.
Interventional Cardiology and Peripheral Vascular Devices Market Companies
- Medtronic (Ireland)
- Boston Scientific (U.S.)
- Abbott (U.S.)
- Johnson & Johnson (U.S.)
- Terumo Corporation (Japan)
- Cordis Corporation (U.S.)
- Siemens Healthineers (Germany)
- Koninklijke Philips N.V. (Netherlands)
- B. Braun Melsungen AG (Germany)
- Edwards Lifesciences (U.S.)
- Cook Medical (U.S.)
- LivaNova PLC (U.K.)
- LeMaitre Vascular (U.S.)
- MicroPort Scientific Corporation (China)
- OrbusNeich (Hong Kong)
- Biotronik (Germany)
- Abbott Vascular (U.S.)
- Terumo Interventional Systems (Japan)
- Avinger, Inc. (U.S.)
- Shockwave Medical (U.S.)
Recent Developments
- In March 2025, a Johnson and Johnson Medtech company named Shockwave Medical launched its Javelin Peripheral IVL Catheter. This device targets calcium in the extremely narrow blood vessels of peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI) patients. The balloon-free design of the Javelin Peripheral IVL Catheter delivers pulses closer to calcified lesions compared to the balloon-based IVL catheter.(Source: https://cardiovascularbusiness.com)
- In February 2025, Teleflex announced its acquisition of Biotronik's vascular intervention business, making a significant move in the interventional cardiovascular and peripheral vascular market. The deal will expand Teleflex's portfolio with drug-coated balloons, drug-eluting stents, and other vascular devices, strengthening its presence in the global interventional market.(Source: https://vascularnews.com)
Segments Covered in the Report
By Product Type
- Angioplasty Stents
- Angioplasty Balloons
- Catheters
- Plaque Modification Devices
- Hemodynamic Flow Alteration
- Structural Heart Devices
- Accessories
By Application
- Coronary Artery Disease (CAD)
- Peripheral Arterial Disease (PAD)
- Aneurysms & Venous Diseases
By End User
- Hospitals
- Ambulatory Surgical Centres (ASCs)
By Region
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting